We are live on
!
Find out more
TG
TRV GP Portfolio holdings
AUM
$18.9M
1-Year Est. Return
541.67%
This Fund
S&P 500
This Quarter
Est. Return
-33.97%
1 Year Est. Return
+541.67%
3 Year Est. Return
+3,178.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.9M
AUM Growth
-$97M
(-66%)
Cap. Flow
-$52.1M
Cap. Flow
% of AUM
-102.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$52.1M |
Sector Composition
| 1 | Healthcare | 100% |
Similar funds
KA
FRGX
DHRFI
SA
YECIP
FFIM
ES
HCMT
TRV GP's Q1 2020 Portfolio in Review
As of Q1 2020, TRV GP held 2 positions worth $50.9M, down 66% from $148M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP withdrew a net $52.1M in Q1 2020, reducing 1 holding. Its largest reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $52.1M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP's biggest Q1 2020 reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $52.1M.
- TRV GP's ten largest holdings make up 100% of its $50.9M portfolio in Q1 2020.
- TRV GP opened 0 new positions and closed 0 in Q1 2020.
- TRV GP's portfolio value fell 66% quarter-over-quarter to $50.9M.
Based on TRV GP's 13F filing for Q1 2020, filed 11 May 2020.